Clinical Trial Results:
A phase I/IIa study to assess the safety and immunogenicity of new malaria vaccine candidates AdCh63 MSP1 alone and with MVA MSP1
Summary
|
|
EudraCT number |
2009-012591-27 |
Trial protocol |
GB |
Global completion date |
22 Sep 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
30 Dec 2016
|
First version publication date |
30 Dec 2016
|
Other versions |
|
Summary report(s) |
VAC037 End of Study Report VAC037 End of Study Report |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.